Global Stent Delivery System Market Overview:
Stent delivery system delivers are designed to deliver a stent to the target site and then deploy the stent, it is used for pushing and guiding catheters. In addition, the pusher tube is used to place the plastic stents over a guidewire with or without a guiding catheter. The use of a stent can improve blood flow and prevent further damage to the heart muscle, it also helps to improve symptoms of heart disease including chest pain breath shortness, and many more. According to the American heart association On regular, someone dies of CVD every 37 seconds in the U.S. There are 2,353 deaths from CVD each day, based on 2017 data. The major driving factor of the stent delivery system is the increasing number of heart diseases, artery diseases across the globe
Growth Drivers
- Growing Incidence of Coronary Artery Disease and Subsequent
- Increasing Geriatric Population
Roadblocks
- Stringent Regulations for Product Approval
Opportunities
- Advancement in Technologies and Emerging Demand from Developing Regions
Challenges
- Availability of Alternative Treatment Methods
Competitive Landscape:
Some of the key players profiled in the report are MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), Translumina GmbH (Germany), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), TERUMO CORPORATION (Japan), STENTYS SA (France), Boston Scientific Corporation (United States) and Biosensors International Group, Ltd. (Singapore). Additionally, following companies can also be profiled that are part of our coverage like Medtronic plc (Ireland) and Abbott Laboratories (U.S.). Analyst at AMA Research see United States Players to retain maximum share of Global Stent Delivery System market by 2026. Considering Market by Stent diameter, the sub-segment i.e. 2.5mm will boost the Stent Delivery System market. Considering Market by Distribution Channel, the sub-segment i.e. Online will boost the Stent Delivery System market. Considering Market by System , the sub-segment i.e. Balloon Expandable Stent will boost the Stent Delivery System market.
For instance, in May 2019 Germany based company B. Braun Interventional has introduced new all in one stent delivery systems named NuDEL. This system was developed in collaboration with NuMED Inc for treating congenital heart defects. In addition, this is a novel product combined with three devices into a single tool, which helps physicians and offers procedural efficiency by eliminating the need to hand crimp or load a mounted stent.
What Can be Explored with the Stent Delivery System Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Stent Delivery System Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Stent Delivery System
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Stent Delivery System market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Stent Delivery System market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Stent Delivery SystemManufacturer, Stent Delivery System Suppliers, Stent Manufacturers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.